Log in or Sign up for Free to view tailored content for your specialty!
Hepatitis C News
HCV screening lags for women, blacks, Hispanics
While hepatitis C screening improved recently, the increased rates are minimal and less than optimal among black individuals, Hispanics and women, according to a recently published study.
ID mortality rate in US decreases almost 20% since 1980
The overall death rate from many infectious diseases decreased by nearly 20% in the United States over 35 years, according to researchers.
Log in or Sign up for Free to view tailored content for your specialty!
New York governor announces state-level HCV elimination strategy
Gov . Andrew M. Cuomo announced the first U.S. state-level hepatitis C elimination strategy to end HCV in New York, according to a press release.
Novel score predicts DAA benefit in patients with HCV, decompensated cirrhosis
Researchers have developed a predictive score that quantifies the potential benefits of direct-acting antiviral therapy for patients with hepatitis C and decompensated cirrhosis, according to recently published data.
Unrestricted access to DAAs nearly eliminates HCV in Australian prison
A program granting prison inmates with hepatitis C virus infection unrestricted access to direct-acting antiviral therapy nearly eliminated the virus at a correctional facility in Australia less than 2 years after its implementation, according to study findings published in Clinical Infectious Diseases.
8-weeks Mavyret therapy effective regardless of patient characteristics
Hepatitis C treatment with Mavyret for 8 weeks had an overall sustained virologic response rate of 98% regardless of baseline patient or viral characteristics in a cohort of patients with genotypes 1 through 6, according to a recently published study.
Treating People Who Inject Drugs: How to Reach a Difficult-to-Engage Population
As a population, people who inject drugs have the highest prevalence and incidence of hepatitis C infection. Despite this, people who inject drugs have historically had difficulty accessing treatment, either due to socioeconomic and stigma-related barriers or due to treatment restrictions for people with ongoing drug and/or alcohol use.
Moving Beyond the Low-Hanging Fruit in HCV Diagnosis and Treatment
The trouble in engaging difficult to reach populations is, well, that they are difficult to reach.
Should ID specialists treat opioid use disorder using medication-assisted therapy?
To address the underlying opioid addiction that so often leads to injection-related infections, experts have suggested that directly treating the addiction should be a priority for ID specialists. We asked Peter Chin-Hong, MD, a professor of medicine at the University of California, San Francisco School of Medicine and Infectious Disease News Editorial Board member, if he agrees that ID specialists should treat opioid use disorder with medicine.
ID physicians define new role in opioid crisis
The opioid epidemic in the United States has affected millions, exposing them to health risks that include a range of infectious diseases.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read